Literature DB >> 9028359

Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa.

K E Anderson1, T A Sellers, P L Chen, S S Rich, C P Hong, A R Folsom.   

Abstract

BACKGROUND: The Stein-Leventhal syndrome (SLS), first described in 1935, is characterized by infertility, hyperandrogenization, and obesity. Because this phenotype represents an aggregation of risk factors for postmenopausal breast carcinoma, and because in general, a hormonal imbalance underlies the disorder, the authors examined the association between self-reported SLS and breast carcinoma incidence in a cohort of 34,835 cancer-free women assembled in 1986 and followed through 1992.
METHODS: All participants were between the ages of 55 and 69 and held a valid Iowa driver's license. A total of 472 women in the cohort (1.35%) reported a history of SLS at baseline. Incident cases of breast carcinoma were identified annually using the State Health Registry of Iowa. Data were analyzed using Cox proportional hazards regression.
RESULTS: During the follow-up period, there were 883 incident breast carcinomas, 14 among women reporting a history of SLS. Women with SLS were more likely than women without SLS to report fertility problems and menstrual irregularities, but there were no significant differences observed regarding body mass index (BMI). Although women with SLS were 1.8 times as likely to report benign breast disease than women without SLS (P < 0.01), they were not more likely to develop breast carcinoma (relative risk [RR] = 1.2; 95% confidence interval [CI] = 0.7-2). Adjustment for age at menarche, age at menopause, parity, oral contraceptive use, BMI, waist-to-hip ratio, and family history of breast carcinoma lowered the RR to 1 (95% CI = 0.6-1.9.
CONCLUSIONS: Despite the high risk profiles of some women with SLS, these results do not suggest that the syndrome per se is associated with an increased risk of postmenopausal breast carcinoma.

Entities:  

Mesh:

Year:  1997        PMID: 9028359

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Menstrual cycle characteristics and incidence of premenopausal breast cancer.

Authors:  Kathryn L Terry; Walter C Willett; Janet W Rich-Edwards; David J Hunter; Karin B Michels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-06       Impact factor: 4.254

2.  Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome).

Authors:  Louise A Brinton; Kamran S Moghissi; Carolyn L Westhoff; Emmet J Lamb; Bert Scoccia
Journal:  Fertil Steril       Date:  2009-11-25       Impact factor: 7.329

3.  Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case-control study.

Authors:  Jayeon Kim; Jennifer E Mersereau; Nikhil Khankari; Patrick T Bradshaw; Lauren E McCullough; Rebecca Cleveland; Sumitra Shantakumar; Susan L Teitelbuam; Alfred I Neugut; Ruby T Senie; Marilie D Gammon
Journal:  Cancer Causes Control       Date:  2016-01-21       Impact factor: 2.506

Review 4.  Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  John A Barry; Mallika M Azizia; Paul J Hardiman
Journal:  Hum Reprod Update       Date:  2014-03-30       Impact factor: 15.610

Review 5.  Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis.

Authors:  Verónica Yumiceba; Andrés López-Cortés; Andy Pérez-Villa; Iván Yumiseba; Santiago Guerrero; Jennyfer M García-Cárdenas; Isaac Armendáriz-Castillo; Patricia Guevara-Ramírez; Paola E Leone; Ana Karina Zambrano; César Paz-Y-Miño
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-26       Impact factor: 5.555

6.  If progesterone is blamed for breast cancer development, why are we still using tamoxifen?

Authors:  Enis Ozkaya; Vakkas Korkmaz; Tuncay Kucukozkan; Fadil Kara
Journal:  J Breast Cancer       Date:  2013-03-31       Impact factor: 3.588

Review 7.  Polycystic ovary syndrome: clinical implication in perimenopause.

Authors:  Monika Lenart-Lipińska; Beata Matyjaszek-Matuszek; Ewa Woźniakowska; Janusz Solski; Jerzy S Tarach; Tomasz Paszkowski
Journal:  Prz Menopauzalny       Date:  2014-12-30

8.  The association between polycystic ovary syndrome and breast cancer: a meta-analysis.

Authors:  Fatemeh Shobeiri; Ensiyeh Jenabi
Journal:  Obstet Gynecol Sci       Date:  2016-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.